Spanish Red Biotech Pipeline

Novo Nordisk Pharma

Faster-acting insulin aspart (FIAsp)

Type: Biodrugs/ Drugs
Therapeutic area: Metabolic / Endocrinology
Indication: Diabetes type 1 and type 2
Phase: 4Registration, 3Phase III in Spain, 2Phase II, 1Phase I